United Therapeutics Net Profit Margin 2010-2025 | UTHR

Current and historical net profit margin for United Therapeutics (UTHR) from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. United Therapeutics net profit margin for the three months ending March 31, 2025 was .
United Therapeutics Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-03-31 $2.99B $1.21B 40.41%
2024-12-31 $2.88B $1.20B 41.52%
2024-09-30 $2.76B $1.11B 40.30%
2024-06-30 $2.62B $1.07B 40.89%
2024-03-31 $2.50B $1.05B 42.06%
2023-12-31 $2.33B $0.99B 42.31%
2023-09-30 $2.21B $0.90B 40.82%
2023-06-30 $2.11B $0.87B 41.24%
2023-03-31 $1.98B $0.73B 36.73%
2022-12-31 $1.94B $0.73B 37.53%
2022-09-30 $1.86B $0.71B 38.01%
2022-06-30 $1.79B $0.63B 35.27%
2022-03-31 $1.77B $0.69B 38.89%
2021-12-31 $1.69B $0.48B 28.23%
2021-09-30 $1.66B $0.46B 27.96%
2021-06-30 $1.59B $0.47B 29.60%
2021-03-31 $1.51B $0.41B 26.89%
2020-12-31 $1.48B $0.52B 34.73%
2020-09-30 $1.41B $0.47B 33.29%
2020-06-30 $1.43B $0.43B 30.05%
2020-03-31 $1.44B $0.53B 36.59%
2019-12-31 $1.45B $-0.11B -7.24%
2019-09-30 $1.52B $-0.09B -6.12%
2019-06-30 $1.53B $-0.12B -7.71%
2019-03-31 $1.60B $-0.15B -9.36%
2018-12-31 $1.63B $0.59B 36.24%
2018-09-30 $1.71B $0.54B 31.78%
2018-06-30 $1.75B $0.71B 40.86%
2018-03-31 $1.75B $0.48B 27.74%
2017-12-31 $1.73B $0.42B 24.20%
2017-09-30 $1.67B $0.51B 30.46%
2017-06-30 $1.63B $0.40B 24.19%
2017-03-31 $1.60B $0.66B 41.04%
2016-12-31 $1.60B $0.71B 44.65%
2016-09-30 $1.60B $0.71B 44.45%
2016-06-30 $1.57B $1.01B 64.27%
2016-03-31 $1.51B $0.90B 59.99%
2015-12-31 $1.47B $0.65B 44.41%
2015-09-30 $1.41B $0.66B 47.05%
2015-06-30 $1.35B $0.17B 12.81%
2015-03-31 $1.33B $0.19B 14.02%
2014-12-31 $1.29B $0.34B 26.48%
2014-09-30 $1.23B $0.20B 15.84%
2014-06-30 $1.20B $0.28B 23.52%
2014-03-31 $1.16B $0.25B 21.62%
2013-12-31 $1.12B $0.18B 15.67%
2013-09-30 $1.07B $0.29B 26.87%
2013-06-30 $1.01B $0.30B 29.94%
2013-03-31 $0.96B $0.30B 30.83%
2012-12-31 $0.92B $0.30B 33.19%
2012-09-30 $0.87B $0.26B 30.45%
2012-06-30 $0.83B $0.27B 32.65%
2012-03-31 $0.79B $0.27B 34.65%
2011-12-31 $0.74B $0.22B 29.17%
2011-09-30 $0.71B $0.18B 25.92%
2011-06-30 $0.68B $0.14B 20.68%
2011-03-31 $0.63B $0.10B 16.56%
2010-12-31 $0.59B $0.11B 18.01%
2010-09-30 $0.53B $0.09B 17.70%
2010-06-30 $0.46B $0.07B 14.38%
2010-03-31 $0.41B $0.03B 6.37%
2009-12-31 $0.36B $0.02B 5.57%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.473B $2.877B
United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $99.323B 37.26
Zoetis (ZTS) United States $70.523B 26.70
Daiichi Sankyo, - (DSNKY) Japan $49.922B 25.40
Takeda Pharmaceutical (TAK) Japan $48.938B 10.83
Summit Therapeutics (SMMT) United States $20.810B 0.00
Sandoz Group AG (SDZNY) Switzerland $19.664B 0.00
Merck (MKKGY) Germany $18.359B 15.19
Shionogi (SGIOY) Japan $14.547B 14.57
Neurocrine Biosciences (NBIX) United States $10.858B 37.20
IPSEN (IPSEY) France $9.940B 0.00
Orion OYJ (ORINY) Finland $9.075B 24.54
Corcept Therapeutics (CORT) United States $7.841B 63.74
Madrigal Pharmaceuticals (MDGL) United States $6.803B 0.00
Stevanato Group S.p.A (STVN) Italy $6.702B 42.56
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Ionis Pharmaceuticals (IONS) United States $5.355B 0.00
Grifols, S.A (GRFS) Spain $5.122B 0.00
Soleno Therapeutics (SLNO) United States $3.817B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.151B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.964B 12.03
Hypermarcas (HYPMY) Brazil $2.350B 15.46
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.337B 12.78
BioCryst Pharmaceuticals (BCRX) United States $2.308B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.223B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.911B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.807B 0.00
Indivior (INDV) United States $1.641B 6.96
Guardian Pharmacy Services (GRDN) United States $1.610B 0.00
Evotec AG (EVO) Germany $1.481B 0.00
ARS Pharmaceuticals (SPRY) United States $1.400B 178.25
Dyne Therapeutics (DYN) United States $1.344B 0.00
Ocular Therapeutix (OCUL) United States $1.231B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.129B 45.89
Enliven Therapeutics (ELVN) United States $1.000B 0.00
Harrow (HROW) United States $0.907B 0.00
Ardelyx (ARDX) United States $0.894B 0.00
Collegium Pharmaceutical (COLL) United States $0.893B 4.74
Avadel Pharmaceuticals (AVDL) Ireland $0.874B 0.00
Xencor (XNCR) United States $0.763B 0.00
AleAnna (ANNA) United States $0.743B 0.00
Cronos Group (CRON) Canada $0.732B 0.00
Xeris Biopharma Holdings (XERS) United States $0.726B 0.00
Organogenesis (ORGO) United States $0.675B 0.00
KalVista Pharmaceuticals (KALV) United States $0.651B 0.00
Akebia Therapeutics (AKBA) United States $0.613B 0.00
Bioventus (BVS) United States $0.576B 14.96
Savara (SVRA) United States $0.567B 0.00
Relay Therapeutics (RLAY) United States $0.566B 0.00
USANA Health Sciences (USNA) United States $0.546B 11.71
Regulus Therapeutics (RGLS) United States $0.520B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.515B 0.00
CytoDyn (CYDY) United States $0.511B 0.00
Verve Therapeutics (VERV) United States $0.460B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.459B 0.00
Elite Pharmaceuticals (ELTP) United States $0.455B 0.00
Zevra Therapeutics (ZVRA) United States $0.437B 0.00
Altimmune (ALT) United States $0.418B 0.00
Tourmaline Bio (TRML) United States $0.409B 0.00
Siga Technologies (SIGA) United States $0.386B 6.59
Oruka Therapeutics (ORKA) United States $0.374B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.341B 20.33
Heron Therapeutics (HRTX) United States $0.325B 0.00
Aquestive Therapeutics (AQST) United States $0.281B 0.00
Avita Medical (RCEL) United States $0.243B 0.00
Wellgistics Health (WGRX) United States $0.237B 0.00
Nature's Sunshine Products (NATR) United States $0.231B 27.17
ProKidney (PROK) United States $0.220B 0.00
Esperion Therapeutics (ESPR) United States $0.208B 26.25
OmniAb (OABI) United States $0.205B 0.00
MediWound (MDWD) Israel $0.191B 0.00
Larimar Therapeutics (LRMR) United States $0.172B 0.00
Nanobiotix S.A (NBTX) France $0.167B 0.00
Korro Bio (KRRO) United States $0.166B 0.00
4D Molecular Therapeutics (FDMT) United States $0.165B 0.00
Profound Medical (PROF) Canada $0.164B 0.00
Aldeyra Therapeutics (ALDX) United States $0.162B 0.00
Journey Medical (DERM) United States $0.159B 0.00
Inhibikase Therapeutics (IKT) United States $0.155B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.150B 46.38
Lexeo Therapeutics (LXEO) United States $0.148B 0.00
Aclaris Therapeutics (ACRS) United States $0.139B 0.00
Protara Therapeutics (TARA) United States $0.131B 0.00
Lyell Immunopharma (LYEL) United States $0.128B 0.00
Nektar Therapeutics (NKTR) United States $0.128B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.126B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.116B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
VAXART, INC (VXRT) United States $0.095B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Champions Oncology (CSBR) United States $0.083B 13.68
Galectin Therapeutics (GALT) United States $0.083B 0.00
Fractyl Health (GUTS) United States $0.080B 0.00
Unicycive Therapeutics (UNCY) United States $0.078B 0.00
Cassava Sciences (SAVA) United States $0.077B 0.00
Telomir Pharmaceuticals (TELO) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Context Therapeutics (CNTX) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.062B 0.00
Vivani Medical (VANI) United States $0.061B 0.00
Karyopharm Therapeutics (KPTI) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Metagenomi (MGX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Assertio Holdings (ASRT) United States $0.058B 0.00
Avalo Therapeutics (AVTX) United States $0.054B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
PMV Pharmaceuticals (PMVP) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Acrivon Therapeutics (ACRV) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Prelude Therapeutics (PRLD) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Surrozen (SRZN) United States $0.034B 0.00
FibroGen (FGEN) United States $0.032B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
BioVie (BIVI) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Mannatech (MTEX) United States $0.019B 7.60
DURECT (DRRX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Relmada Therapeutics (RLMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 9.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Plus Therapeutics (PSTV) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.14
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Conduit Pharmaceuticals (CDT) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00